Richard Vellacott is no longer serving in their board position at Horizon Discovery Ltd.

Jan 31, 2019
Board and Executive Moves
Background Information
Horizon Discovery Ltd. develops and supplying patient-relevant drug discovery and diagnostic research tools. The company also supplies genetically-defined cell lines, reporter gene assay kits, genomic reference standards and contract research services to organizations engaged in bio-pharmaceutical process optimization, drug discovery & development, and clinical diagnostic development. Horizon Discovery was founded by Christopher John Torrance and Alberto Bardelli on February 14, 2005 and is headquartered in Cambridge, the United Kingdom.